An antibacterial composition of thienamycin-type compound and a dipeptidase inhibitor.

摘要

A novel antibacterial drug combination is provided, one component being a fused ring beta -lactam, such as thienamycin and its semi-synthetic derivatives, and the other component is a dipeptidase (E.C. 3.4.13.11) inhibitor. The dual-component combination is formulated so that 1 to 3 parts by weight of the beta -lactam compound are employed for 30 to 1 parts by weight of the inhibitor compound.